Presentation
The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy
Hematology/Oncology Grand Rounds, University of Miami
(2014)
Disciplines
Publication Date
June 25, 2014
Citation Information
Lauren Carcas. "The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy" Hematology/Oncology Grand Rounds, University of Miami (2014) Available at: http://works.bepress.com/lauren-carcas/12/